Regeneron stock gains on Q3 beat (REGN:NASDAQ)
· seekingalpha.com
Regeneron Pharmaceuticals (REGN) stock rises as the company posts higher-than-expected Q3 2026 results thanks to its Sanofi (SNY) collaboration. Read more here.
Shares of Regeneron Pharmaceuticals (REGN) rose in premarket trading on Friday after the Eylea maker reported higher-than-expected Q3 2026 results thanks to ~36...